Toll-like receptor 4 plays a key role in advanced glycation end products-induced M1 macrophage polarization

Zhongwei Liu1, Yanpeng Ma1, Qianwei Cui1

  • 1Department of Cardiology, Shaanxi Provincial People's Hospital, Xi'an, Shaanxi, China.

Abstract

Insights

Advanced glycation end products (AGEs) drive M1 macrophage polarization through the RAGE/ROS/TLR4/STAT1 pathway. Inhibiting Toll-like receptor 4 (TLR4) reduces this polarization, offering potential therapeutic targets.

Area of Science:

  • Immunology
  • Cell Biology
  • Biochemistry

Background:

  • Macrophage polarization is crucial in immune responses.
  • Advanced glycation end products (AGEs) are implicated in various diseases.
  • Toll-like receptor 4 (TLR4) plays a role in innate immunity and inflammation.

Purpose of the Study:

  • To investigate the role of Toll-like receptor 4 (TLR4) in AGEs-induced macrophage polarization towards the M1 phenotype.
  • To elucidate the signaling pathway involved in AGEs-mediated M1 polarization.

Main Methods:

  • Primary macrophages were treated with AGEs and/or hydrogen peroxide (H2O2).
  • Receptor for AGEs (RAGE) was over-expressed, and TLR4 was silenced using siRNA or inhibited with TAK-242.
  • Intracellular reactive oxygen species (ROS) were measured using DCFH-DA.
  • M1 macrophage markers (iNOS), gene and protein expression (TLR4, RAGE, STAT1), and cytokine levels (IL6, IL12, TNFα) were assessed.

Main Results:

  • AGEs increased ROS generation, iNOS expression, RAGE, TLR4, STAT1 activation, and pro-inflammatory cytokines (IL6, IL12, TNFα) in a dose-dependent manner.
  • TLR4 inhibition or silencing reduced RAGE, TLR4, and STAT1 activation without affecting ROS or RAGE expression.
  • RAGE over-expression and H2O2 treatment elevated ROS and TLR4 levels.

Conclusions:

  • AGEs induce M1 macrophage polarization via the RAGE/ROS/TLR4/STAT1 signaling pathway.
  • Targeting TLR4 may be a therapeutic strategy for AGEs-related inflammatory conditions.